Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
909 hedge funds and large institutions have $51.9B invested in Celgene Corp in 2013 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 295 increasing their positions, 406 reducing their positions, and 43 closing their positions.
123% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 43
76% more funds holding in top 10
Funds holding in top 10: 55 → 97 (+42)
32% more capital invested
Capital invested by funds: $39.2B → $51.9B (+$12.7B)
5% more funds holding
Funds holding: 866 → 909 (+43)
13% less call options, than puts
Call options by funds: $831M | Put options by funds: $951M
27% less repeat investments, than reductions
Existing positions increased: 295 | Existing positions reduced: 406
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Marsico Capital Management
Denver,
Colorado
|
+$342M |
| 2 |
JP Morgan Chase
New York
|
+$161M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$156M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$134M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$115M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$369M |
| 2 |
D.E. Shaw & Co
New York
|
-$136M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$91M |
| 4 |
Renaissance Technologies
New York
|
-$80.1M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$78.5M |
CELG Hedge Fund Activity: Q3 2013 in Review
909 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2013, worth a combined $51.9B — up 32% from $39.2B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new CELG positions and 43 closed out — a net gain of 53 holders — while 295 added to existing stakes and 406 trimmed.
The largest buyer was Marsico Capital Management, adding an estimated $342M. The largest seller was Capital World Investors, cutting an estimated $369M.
- 909 institutional investors held Celgene Corp (CELG) as of Q3 2013, up from 866 in Q2 2013.
- Funds reported $51.9B of Celgene Corp stock for Q3 2013, up 32% quarter-over-quarter.
- 96 funds opened new Celgene Corp positions in Q3 2013 and 43 closed out, a net change of +53 holders.
- The largest Celgene Corp buyer in Q3 2013 was Marsico Capital Management, an estimated $342M added.
- The largest Celgene Corp seller in Q3 2013 was Capital World Investors, an estimated $369M sold.
Based on aggregated 13F filings for Q3 2013.